DoD P&T Committee Executive Summary: Extended Release Opioids
DoD Subclass Review: Extended Release High Potency Opioids, August 2015
Health.mil Planned Outage: Oct. 19, 2026
From about 6-7 p.m. ET, Health.mil will be unavailable while we undergo routine maintenance.
Tell us what you're looking for to find questions and answers about your topic.
We found 869 items
DoD Subclass Review: Extended Release High Potency Opioids, August 2015
DoD Subclass Review: Sodium-Glucose Co-Transporter 2 Inhibitors, August 2015
This document provides a summary of the drug class review for PAH Drugs
This document provides a summary of the drug subclass review for Transmucosal Immediate Release Fentanyl Products
This document provides a summary of the drug subclass review for Oral Oncology Prostate Cancer Drugs
Agenda of the February 11, 2015 Defense Health Board meeting
Meeting Minutes of the February 11, 2015 DHB Meeting
Minutes for the DoD P&T Committee Meeting from February 2015
Uniform Formulary Beneficiary Advisory Panel Meeting Information - June 26, 2024
Background Information - May 2024 P&T Committee Recommendations
Agenda - June 26, 2024. For the May 2024 Department of Defense Pharmacy and Therapeutics Committee Meeting.
Finalized and approved meeting minutes from the Open Meeting of the June 4, 2024 DHB Meeting.
Agenda for the June 4, 2024 Defense Health Board meeting to have two tasker updates and two topic briefs.
Agenda - Uniform Formulary Beneficiary Advisory Panel for the August 2024 Department of Defense Pharmacy and Therapeutics Committee Meeting, September 25, 2024.
UF BAP Agenda - Sept. 25, 2024